IDT Australia: Half Yearly Report and Accounts
Filed with ASX · · 5 pages · English
In the deck
Earlier from IDT Australia
- IDT Australia Investor Highlights 2020
- Appendix 4E
- Cann Group Executes New Export Supply Agreements
- Business Update - COVID-19
- Medicinal Cannabis GMP manufacturing update
Later from IDT Australia
- IDT Australia FY21 Interim Results and Investor Update
- COVID19 Vaccine Feasibility Assessment
- COVID-19 Vaccine Manufacture discussions with VicGov & MIPS
- Response to ASX Price Query
- Media Interest, MIPS COVID-19 Vaccine & Sterile Readiness
Follow IDT Australia into a list and get an email when it puts out news.
Follow IDT Australia